RT Book, Section
A1 Malik, Atif B.
A1 Sohail, Maaz
A1 Bajwa, Zahid H.
A2 Bajwa, Zahid H.
A2 Wootton, R. Joshua
A2 Warfield, Carol A.
SR Print(0)
ID 1131932922
T1 Botulinum Toxins for the Treatment of Headaches
T2 Principles and Practice of Pain Medicine, 3e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071766838
LK neurology.mhmedical.com/content.aspx?aid=1131932922
RD 2024/04/23
AB Since  the  1980s,  botulinum  toxins  (BTXs)  have  been  used  for  many  putative  conditions  that  cause  pain.  The  U.S.  Food  and  Drug  Administration  (FDA)  has  approved  BTX  type  A  as  a  prophylactic  treatment  for  headaches  due  to  chronic  migraines  and  approved  both  BTX  type  A  and  B  for  other  medical  conditions  associated  with  pain  and  discomfort.  Although  BTX  is  currently  not  approved  for  any  other  headache  disorders,  it  continues  to  be  used  successfully  by  a  range  of  specialists  to  address  pain  control.